We are live on ! Find out more
OSRHW

OSR Health Warrant

Delisted

OSRHW was delisted on the 25th of August, 2026.

27 hedge funds and large institutions have $5.63M invested in OSR Health Warrant in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

69% more funds holding

Funds holding: 1627 (+11)

25% less capital invested

Capital invested by funds: $7.52M → $5.63M (-$1.89M)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
27
Holders Change
+11
Holders Change %
+68.75%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
1
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

OSRHW Hedge Fund Activity: Q2 2023 in Review

27 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in OSR Health Warrant (OSRHW) for Q2 2023, worth a combined $5.63M — down 25% from $7.52M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new OSRHW positions and 1 closed out — a net gain of 11 holders — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Rivernorth Capital Management, opening a new position worth an estimated $14K. The largest seller was Oaktree Capital Management, exiting entirely with an estimated $12.3K sold.

  • 27 institutional investors held OSR Health Warrant (OSRHW) as of Q2 2023, up from 16 in Q1 2023.
  • Funds reported $5.63M of OSR Health Warrant stock for Q2 2023, down 25% quarter-over-quarter.
  • 12 funds opened new OSR Health Warrant positions in Q2 2023 and 1 closed out, a net change of +11 holders.
  • The largest OSR Health Warrant buyer in Q2 2023 was Rivernorth Capital Management, an estimated $14K added.
  • The largest OSR Health Warrant seller in Q2 2023 was Oaktree Capital Management, an estimated $12.3K sold.

Based on aggregated 13F filings for Q2 2023.